Genprex, Inc.
Genprex, Inc. (GNPX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GNPX · as of Jun 8, 2026
Key Statistics
Explore Genprex, Inc. Data
gnpx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
gnpx competitorsGNPX
BDRX
BIVI
CERO
CMMB
CNSPStock Performance
Full HistoryAbout Genprex, Inc.
Genprex, Inc. a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lun…
what is genprex, inc. · gnpx stock overview · genprex, inc. company profile · who is genprex, inc. ceo · gnpx NASDAQ · genprex, inc. headquarters · genprex, inc. business segments
About Stock Overview & Key Data
Genprex, Inc. (GNPX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 29, 2018. As of the latest trading session, GNPX stock price is $0.68, with a market capitalization of $1.1M. The stock has returned -95.59% over the past 12 months and -61.05% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Genprex, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Genprex, Inc. reported revenue of — and net income of -$16.2M. For detailed data — including Genprex, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Genprex, Inc. (GNPX) stock price is $0.68. The stock is traded on NASDAQ under the ticker symbol GNPX. The 52-week range is $0.65 – $55.00.